Shengshuang Zhu

Shengshuang Zhu, Ph.D is a Senior Principal Scientist at Arbor Biotechnologies, focusing on non-viral delivery and chemistry of gene-editing payloads. Prior to this role, Shengshuang was a Principal Scientist at Eli Lilly and Company, specializing in RNA therapeutics and LNP development, and at EARLI as a Delivery Bioengineer working on cancer detection and localization techniques. Shengshuang has a strong academic background with a Ph.D in Materials Science and Engineering from Northwestern University and a Bachelor of Arts in Chemistry from Wabash College. Their previous experiences include research and internships at various prestigious institutions like Oak Ridge National Laboratory and the University of Illinois at Urbana-Champaign.